Wellington Partners Life Sciences

Quick Facts

AUM

$500M-$1B

AUM Category

$500M-$1B

Typical Ticket Size

$10M - $50M

Headquarters

Munich, Germany

Founded

2000

Team Size

50-100

About Wellington Partners Life Sciences

Wellington Partners Life Sciences is a prominent private equity firm that specializes in investments within the life sciences sector, focusing on companies that are innovating in biotechnology, pharmaceuticals, and medical technology. The firm adopts a disciplined investment philosophy, emphasizing a thesis-driven approach that seeks to identify and support organizations with transformative potential. Wellington typically invests in companies at various stages of development, from early-stage ventures to later-stage growth companies, with a keen focus on innovation, market potential, and the capabilities of the management teams. The firm’s sector expertise is grounded in an extensive understanding of life sciences, allowing it to effectively evaluate and support portfolio companies that are developing cutting-edge therapies and technologies. Wellington Partners Life Sciences targets companies that have compelling scientific foundations and strong intellectual property, which are crucial for success in the highly competitive life sciences landscape. By leveraging its deep industry knowledge and network, the firm seeks to partner with management teams that share a commitment to advancing healthcare solutions, positioning its portfolio companies for sustained growth and success. Wellington Partners distinguishes itself in the private equity landscape through its dedicated focus on life sciences, combined with a collaborative approach to investment. The firm prioritizes building long-term relationships with its portfolio companies, providing not only capital but also strategic guidance and operational support to help realize their full potential. This partnership-oriented strategy is particularly beneficial for companies facing complex challenges in the rapidly evolving life sciences sector. Interim executives considering collaboration with Wellington Partners Life Sciences should be aware of the firm’s emphasis on innovation and its proactive involvement in portfolio management. The firm values executives who possess a strong operational background in life sciences and who can navigate the intricacies of regulatory environments, market dynamics, and product development processes. Given Wellington's commitment to fostering growth and innovation, interim executives with a track record of driving transformational change will find a supportive and engaged partner in Wellington Partners.

Investment Focus

Sectors: Healthcare

Investment Stages: Venture, Growth

Portfolio Focus: HealthTech

Regional Offices

• London
• Zurich

Connect with Wellington Partners Life Sciences

• Website

Frequently Asked Questions

Is Wellington Partners Life Sciences a private equity firm?

Yes, Wellington Partners Life Sciences is a private equity firm headquartered in Munich, Germany, founded in 2000.

What is Wellington Partners Life Sciences's AUM (assets under management)?

Wellington Partners Life Sciences manages approximately $500M-$1B in assets under management.

What is Wellington Partners Life Sciences's typical ticket size?

Wellington Partners Life Sciences typically invests $10M - $50M per deal.

Where is Wellington Partners Life Sciences headquartered?

Wellington Partners Life Sciences is headquartered in Munich, Germany. Regional offices include London, Zurich.

What sectors does Wellington Partners Life Sciences invest in?

Wellington Partners Life Sciences invests across Healthcare.

What investment stages does Wellington Partners Life Sciences focus on?

Wellington Partners Life Sciences focuses on Venture, Growth investments.

When was Wellington Partners Life Sciences founded?

Wellington Partners Life Sciences was founded in 2000.